newsfilter
← Latest News
GlobeNewswire·

Recro Announces Pricing of $30.0 Million Public Offering of Common Stock

EXTON, Pa., May 12, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. ("Recro"; NASD:REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for companies developing oral solid